MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions
View by Date

Saturday, October 6, 2018

1:45pm-3:15pm
The effects of Nordic walking on gait functions in people with Parkinson’s disease: A long-term pilot study

M. Mak, I. Wong-Yu (Hong Kong, Hong Kong)

Clinical Trials and Therapy in Movement Disorders  ·  Hall 3FG
1:45pm-3:15pm
The effects of STN-DBS on the Parkinson’s disease patients with different progressive rates

R. Qi, H. Yu, J. Li, X. Geng (Kunming, China)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG
1:45pm-3:15pm
The effects of treadmill training augmented by virtual reality on postural control and freezing of gait in Parkinson’s disease

E. Bekkers, A. Mirelman, S. Del Din, L. Avanzino, F. Nieuwhof, J. Hausdorff, A. Nieuwboer (Leuven, Belgium)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG
1:45pm-3:15pm
The efficacy and safety of STN-DBS under general anesthesia for PD patients

W. Chen, L. Chen (Guangzhou, China)

Surgical Therapy: Parkinson's Disease  ·  Hall 3FG
1:45pm-3:15pm
The efficacy of intensive inpatient rehabilitation treatment in Parkinson’s disease patients

J. Shiraishi, T. Okazaki, S. Saeki (Fukuoka, Japan)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG
1:45pm-3:15pm
The establishment of Deep Brain Stimulation Nurse Association (DBSNA) in United Kingdom (UK)

J. Candelario-Mckeown, L. Partington-Smith, U. Brechany, L. Mooney-Messer, J. Kausar, B. Forrow, S. Perides, L. Nelson (London, United Kingdom)

Education in Movement Disorders  ·  Hall 3FG
1:45pm-3:15pm
The first case of Perry syndrome in Estonia

K. Vender, T. Toomsoo, I. Kalju, I. Rubanovits, K. Joost, P. Taba (Tallinn, Estonia)

Rare Genetic and Metabolic Diseases  ·  Hall 3FG
1:45pm-3:15pm
The FOsmetpantotenate Replacement Therapy (FORT) Pivotal Trial: Utilization of a Novel Primary Efficacy Outcome in Patients with Pantothenate Kinase-Associated Neurodegeneration

F. Greblikas, M. Escolar, T. Klopstock, R. Marshall, B. Perez, S. Tuller, A. Videnovic (San Diego, CA, USA)

Clinical Trials and Therapy in Movement Disorders  ·  Hall 3FG
1:45pm-3:15pm
The highly selective 5-HT2A receptor antagonist EMD-281,014 alleviates L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson’s disease

I. Frouni, D. Bedard, S. Belliveau, E. Bourgeois-Cayer, A. Hamadjida, P. Huot (Montreal, QC, Canada)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG
1:45pm-3:15pm
The History of Huntington Disease Description in Russia

D. Labunskiy (Santa Rosa, CA, USA)

History  ·  Hall 3FG
  • «Previous Page
  • 1
  • …
  • 52
  • 53
  • 54
  • 55
  • 56
  • …
  • 59
  • Next Page»

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley